FDA Withholds Antibiotic Approval, Asks For More Tests

Law360, New York (October 23, 2006, 12:00 AM EDT) -- The U.S. Food and Drug Administration has refused to allow Replidyne Inc. and Forest Laboratories Inc. to market an oral antibiotic and has requested further testing, the companies said Monday.

The companies said that the FDA issued a non-approvable letter for the new drug application for oral antibiotic faropenem medoxomil.

“In its letter the FDA did not raise any safety concerns or chemistry, manufacturing or controls issues related to the product,” the companies said. “Replidyne and Forest intend to discuss the clinical plans with the FDA...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.